drugset / Trial / NCT07524946
Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo
Phase 4
Not yet recruiting
100 enrolled
Bausch Health Americas, Inc.
MedTrials Incorporated · collab
NaSingle-groupOpen-labelTreatment
Summary
This study is to evaluate the safety, pharmacokinetics, and treatment effect for topically applied CABTREO lotion in pediatric participants ages 9 to 11 years, 11 months with Acne Vulgaris.
Timeline
- Start
- 2026-04
- Primary completion
- 2027-12
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CABTREO | Unknown | 0.15 % | Topical |
| Subject | CABTREO | Unknown | 1.2 % | Topical |
| Subject | CABTREO | Unknown | 3.1 % | Topical |